Ernexa Therapeutics Inc. (ERNA) EBITDA (2010 - 2026)
Ernexa Therapeutics' (ERNA) quarterly EBITDA came in at -$5.6 million in Q1 2026, down 104.76% YoY from $117.4 million in Q1 2025, and down 166.95% on a QoQ basis from -$2.1 million in Q4 2025.
Ernexa Therapeutics Inc. (ERNA) EBITDA (2010 - 2026) Analysis & Trends
Ernexa Therapeutics (ERNA) has 17 years of EBITDA data on file, last reported at -$5.6 million in Q1 2026.
- Quarterly EBITDA fell 104.76% year-over-year to -$5.6 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$12.2 million (up 3.48% YoY) and the FY2025 annual result came in at -$9.3 million, up 40.54% from the prior year.
- EBITDA eased to -$5.6 million in Q1 2026, from -$2.1 million in the prior quarter.
- In the past five years, EBITDA ranged from a high of -$2.0 million in Q3 2025 to a low of -$13.9 million in Q2 2022.
- A 5-year average of -$5.0 million and a median of -$4.9 million in 2024 frame the typical range for EBITDA.
- Annual changes were most pronounced in 2022 — EBITDA surged 90.38% — and 2026, when it slumped 104.76%.
- Tracing ERNA's EBITDA over 5 years: stood at -$4.7 million in 2022, then retreated by 21.7% to -$5.8 million in 2023, then jumped by 53.22% to -$2.7 million in 2024, then grew by 22.36% to -$2.1 million in 2025, then sank by 166.95% to -$5.6 million in 2026.
- The last three EBITDA figures came in at -$5.6 million (Q1 2026), -$2.1 million (Q4 2025), and -$2.0 million (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -4.10 Mn |
| Mar 31, 2026 | -5.59 Mn |
| Dec 31, 2025 | -2.09 Mn |
| Sep 30, 2025 | -1.99 Mn |
| Jun 30, 2025 | -2.50 Mn |
| Mar 31, 2025 | -2.73 Mn |
| Dec 31, 2024 | -2.70 Mn |
| Sep 30, 2024 | -2.26 Mn |
| Jun 30, 2024 | -4.93 Mn |
| Mar 31, 2024 | -5.79 Mn |
| Dec 31, 2023 | -5.77 Mn |
| Sep 30, 2023 | -5.51 Mn |
| Jun 30, 2023 | -4.55 Mn |
| Mar 31, 2023 | -5.32 Mn |
| Dec 31, 2022 | -4.74 Mn |
| Sep 30, 2022 | -8.30 Mn |
| Jun 30, 2022 | -13.88 Mn |
| Mar 31, 2022 | -6.30 Mn |
| Dec 31, 2021 | -8.52 Mn |
| Sep 30, 2021 | -86.28 Mn |